ARCHIVES

FDA Advisors Unanimously Turn Down GPC Biotech’s Orplatna for Prostate Cancer.

This article is from The Cancer Letter archive.

Vol. 33 No. 29 | July 27, 2007

Download PDF Visit The Full Archive

Related Articles

NIH Considering Intramural NRSA, NCI Advisors Not Enthusiastic

February 17, 1984

Four Win 1988 General Motors Cancer Prizes

June 17, 1988

Centers Core Support To Be Trimmed By Dropping Funds for Scientists Salaries, Shared Resources

September 23, 1977

Questions Raised By Committee Kills Still Not Resolved

July 29, 1977

NCI Leaders, Others Defend Cancer Program Against Bailar’s Charge They Are Losing War Against Cancer

May 16, 1986

PDQ Used Mainly For Information To Public, Not Much By Non-Oncologists, Evaluation Finds

August 18, 1989